Recent Advances in the Biological Study of Personality Disorders

Psychiatric Clinics of North America

Volumn 31, Issue 3, 2008, Pages 441-461

  New, Antonia S ^a,b   Goodman, Marianne ^a,b   Triebwasser, Joseph ^a,b   Siever, Larry J ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; FLUORODEOXYGLUCOSE F 18; OPIATE;

AMYGDALOID NUCLEUS; BORDERLINE STATE; CINGULATE GYRUS; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HIPPOCAMPUS; HUMAN; NEUROIMAGING; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCHIZOTYPAL PERSONALITY DISORDER; SEROTONINERGIC SYSTEM;

AMYGDALA; AROUSAL; BORDERLINE PERSONALITY DISORDER; BRAIN; EMOTIONS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE NET; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RECEPTORS, OPIOID; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; SEROTONIN;

EID: 47049117355     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2008.03.011     Document Type: Review

References (161)

1. Siever L.J., and Davis K.L. A psychobiological perspective on the personality disorders. Am J Psychiatry 148 12 (1991) 1647-1658
2. Loranger A.W., Oldham J.M., and Tulis E.H. Familial transmission of DSM-III borderline personality disorder. Arch Gen Psychiatry 39 7 (1982) 795-799
3. Kendler K.S., Neale M.C., and Walsh D. Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study. Am J Psychiatry 152 5 (1995) 749-754
4. Kendler K.S., and Gardner C.O. The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies. Psychol Med 27 2 (1997) 411-419
5. Torgersen S., Lygren S., Oien P.A., et al. A twin study of personality disorders. Compr Psychiatry 41 6 (2000) 416-425
6. Ji W.Y., Hu Y.H., Huang Y.Q., et al. A twin study of personality disorder heritability. Zhonghua Liu Xing Bing Xue Za Zhi 27 2 (2006) 137-141 [in Chinese]
7. Coolidge F.L., Thede L.L., and Jang K.L. Heritability of personality disorders in childhood: a preliminary investigation. J Personal Disord 15 1 (2001) 33-40
8. Kendler K.S., Czajkowski N., Tambs K., et al. Dimensional representations of DSM-IV cluster A personality disorders in a population-based sample of Norwegian twins: a multivariate study. Psychol Med 36 11 (2006) 1583-1591
9. Kendler K.S., Myers J., Torgersen S., et al. The heritability of cluster A personality disorders assessed by both personal interview and questionnaire. Psychol Med 37 5 (2007) 655-665
10. Lin C.C., Su C.H., Kuo P.H., et al. Genetic and environmental influences on schizotypy among adolescents in Taiwan: a multivariate twin/sibling analysis. Behav Genet 37 2 (2007) 334-344
11. Linney Y.M., Murray R.M., Peters E.R., et al. A quantitative genetic analysis of schizotypal personality traits. Psychol Med 33 5 (2003) 803-816
12. Friedel R.O. Dopamine dysfunction in borderline personality disorder: a hypothesis. Neuropsychopharmacology 29 6 (2004) 1029-1039
13. Joyce P.R., McHugh P.C., McKenzie J.M., et al. A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients. Psychol Med 36 6 (2006) 807-813
14. Philipsen A., Richter H., Schmahl C., et al. Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder. J Clin Psychiatry 65 10 (2004) 1414-1419
15. Simeon D., Knutelska M., Smith L., et al. A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation. Psychiatry Res 149 1-3 (2007) 177-184
16. Salzman C., Wolfson A.N., Schatzberg A., et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 15 1 (1995) 23-29
17. Coccaro E.F., and Kavoussi R.J. Fluoxetine and impulsive aggressive behavior in personality disordered subjects. Arch Gen Psychiatry 54 (1997) 1081-1088
18. Kavoussi R.J., Liu J., and Coccaro E.F. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 55 4 (1994) 137-141
19. Brown G.L., Ebert M.H., Goyer P.F., et al. Aggression, suicide, and serotonin relationships to CSF amine metabolites. Am J Psychiatry 139 (1982) 741-746
20. Gardner D.L., Lucas P.B., and Cowdry R.W. CSF metabolites in borderline personality disorder compared with normal controls. Biol Psychiatry 28 (1990) 247-254
21. Linnoila M., DeJong J., and Virkkunen M. Family history of alcoholism in violent offenders and impulsive fire setters. Arch Gen Psychiatry 46 (1989) 613-616
22. Linnoila M., Virkkunen M., George T., et al. Serotonin, violent behavior and alcohol. In: Jansson B., Jornvall H., and Rydberg U. (Eds). Toward a molecular basis of alcohol use and abuse (1994), Birkhauser Verlag Base, Switzerland 155-164
23. Virkkunen M., Rawlings R., Tokola R., et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 51 1 (1994) 20-27
24. Stanley B., Molcho A., Stanley M., et al. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry 157 4 (2000) 609-614
25. Lidberg L., Belfrage H., Bertilsson L., et al. Suicide attempts and impulse control disorder are related to low cerebrospinal fluid 5-HIAA in mentally disordered violent offenders. Acta Psychiatr Scand 101 5 (2000) 395-402
26. Roy A., Adinoff B., and Linnoila M. Acting out hostility in normal volunteers: negative correlation with levels of 5-HIAA in cerebrospinal fluid. Psychiatry Res 24 (1988) 187-194
27. Traskman-Bendz L., Asberg M., and Schalling D. Serotonergic function and suicidal behavior in personality disorders. Ann N Y Acad Sci 487 (1986) 168-174
28. Coccaro E., Siever L., Klar M., et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 44 (1989) 573-588
29. O'Keane V., Maloney E., O'Neil H., et al. Blunted prolactin response to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry 160 (1992) 643-646
30. Coccaro E., Kavoussi R., Oakes M., et al. 5HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects. Psychopharmacology (Berl) 126 1 (1996) 24-30
31. Ng Ying Kin N.M., Paris J., Schwartz G., et al. Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder. Psychopharmacology (Berl) 182 3 (2005) 447-451
32. Schmahl C., and Bremner J.D. Neuroimaging in borderline personality disorder. J Psychiatr Res 40 5 (2006) 419-427
33. Ni X., Chan K., Bulgin N., et al. Association between serotonin transporter gene and borderline personality disorder. J Psychiatr Res 40 5 (2006) 448-453
34. Steiger H., Richardson J., Joober R., et al. The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with bulimic syndromes. J Psychiatry Neurosci 32 5 (2007) 354-362
35. Pascual J.C., Soler J., Barrachina J., et al. Failure to detect an association between the serotonin transporter gene and borderline personality disorder. J Psychiatr Res 42 1 (2008) 87-88
36. Pascual J., Soler J., Baiget M., et al. Association between the serotonin transporter gene and personality traits in borderline personality disorder patients evaluated with Zuckerman-Kuhlman Personality Questionnaire (ZKPQ). Actas Esp Psiquiatr 35 6 (2007) 382-386
37. Silva H., Iturra P., Solari A., et al. Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder. Actas Esp Psiquiatr 35 6 (2007) 387-392
38. Ansorge M.S., Zhou M., Lira A., et al. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306 5697 (2004) 879-881
39. Lauder J.M. Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Ann N Y Acad Sci 600 (1990) 297-313 [discussion: 314]
40. Lovejoy E.A., Scott A.C., Fiskerstrand C.E., et al. The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit. Eur J Neurosci 17 2 (2003) 417-420
41. Parsey R.V., Hastings R.S., Oquendo M.A., et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 163 1 (2006) 48-51
42. Zaboli G., Gizatullin R., Nilsonne A., et al. Tryptophan hydroxylase-1 gene variants associate with a group of suicidal borderline women. Neuropsychopharmacology 31 9 (2006) 1982-1990
43. Ni X., Sicard T., Bulgin N., et al. Monoamine oxidase A gene is associated with borderline personality disorder. Psychiatr Genet 17 3 (2007) 153-157
44. Nomura M., Kusumi I., Kaneko M., et al. Involvement of a polymorphism in the 5-HT2A receptor gene in impulsive behavior. Psychopharmacology (Berl) 187 1 (2006) 30-35
45. Giegling I., Hartmann A.M., Moller H.J., et al. Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. J Affect Disord 96 1-2 (2006) 75-81
46. Ni X., Bismil R., Chan K., et al. Serotonin 2A receptor gene is associated with personality traits, but not to disorder, in patients with borderline personality disorder. Neurosci Lett 408 3 (2006) 214-219
47. Russ M.J., Roth S.D., Lerman A., et al. Pain perception in self-injurious patients with borderline personality disorder. Biol Psychiatry 32 6 (1992) 501-511
48. Schmahl C.G., Vermetten E., Elzinga B.M., et al. A positron emission tomography study of memories of childhood abuse in borderline personality disorder. Biol Psychiatry 55 7 (2004) 759-765
49. Kemperman I., Russ M.J., Clark W.C., et al. Pain assessment in self-injurious patients with borderline personality disorder. Psychiatry Res 70 3 (1997) 175-183
50. Bohus M., Landwehrmeyer G.B., Stiglmayr C., et al. Naltrexone in the treatment of dissosciative symptoms in patients with borderline personality disorder. J Clin Psychiatry 60 (1999) 598-603
51. Griengl H., and Dantendorfer K. Naltrexone as a treatment of self-injurious behavior: a case report. Eur Psychiatry 16 3 (2001) 193-194
52. McGee M.D. Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone. J Clin Psychiatry 58 1 (1997) 32-33
53. Roth A.S., Ostroff R.B., and Hoffman R.E. Naltrexone as a treatment for repetitive self-injurious behaviour: an open-label trial. J Clin Psychiatry 57 6 (1996) 233-237
54. Gross-Isseroff R., Dillon K.A., Israeli M., et al. Regionally selective increases in mu opioid receptor density in the brains of suicide victims. Brain Res 530 (1990) 312-316
55. Saper J.R., and Lake III A.E. Borderline personality disorder and the chronic headache patient: review and management recommendations. Headache 42 7 (2002) 663-674
56. Kumor K., Su T.P., Vaupel B., et al. Studies of kappa agonist. NIDA Res Monogr 67 (1986) 18-25
57. Schlaepfer T.E., Strain E.C., Greenberg B.D., et al. Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects. Am J Psychiatry 155 4 (1998) 470-473
58. Walsh S.L., Strain E.C., Abreu M.E., et al. A selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl) 157 2 (2001) 151-162
59. Pfeiffer A., Brantl V., Herz A., et al. Psychotomimesis mediated by kappa opiate receptors. Science 233 4765 (1986) 774-776
60. McLean P. The limbic system ("visceral brain") and emotional behaviour. Arch Neurol Psychiatry 73 2 (1955) 130-134
61. Dias R., Robbins T.W., and Roberts A.C. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380 6569 (1996) 69-72
62. Stefanacci L., and Amaral D.G. Some observations on cortical inputs to the macaque monkey amygdala: an anterograde tracing study. J Comp Neurol 451 4 (2002) 301-323
63. Izquierdo A., Suda R.K., and Murray E.A. Comparison of the effects of bilateral orbital prefrontal cortex lesions and amygdala lesions on emotional responses in rhesus monkeys. J Neurosci 25 37 (2005) 8534-8542
64. Davidson R.J., Putnam K.M., and Larson C.L. Dysfunction in the neural circuitry of emotion regulation-a possible prelude to violence. Science 289 (2000) 591-594
65. Blair R.J. The roles of orbital frontal cortex in the modulation of antisocial behavior. Brain Cogn 55 1 (2004) 198-208
66. Anderson S.W., Bechara A., Damasio H., et al. Impairment of social and moral behavior related to early damage in human prefrontal cortex. Nat Neurosci 2 (1999) 1032-1037
67. Pribram K.H., and Bragshaw M. Further analysis of the temporal lobe syndrome utilizing frontotemporal ablation. J Comp Neurol 99 (1953) 347-375
68. Singh S.D. Sociometric analysis of the effects of the bilateral lesion of frontal cortex on the social behavior of rhesus monkeys. Indian J Psychol 51 2 (1976) 144-160
69. Miller B.L., Darby A., Benson D.F., et al. Aggressive, socially disruptive and antisocial behaviour associated with fronto-temporal dementia. Br J Psychiatry 170 (1997) 150-154
70. Damasio H., Grabowski T., Frank R., et al. The return of Phineas Gage: clues about the brain from the skull of a famous patient. Science 264 (1994) 1102-1105
71. Tebartz van Elst L., Hesslinger B., Thiel T., et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry 54 2 (2003) 163-171
72. Rusch N., van Elst L.T., Ludaescher P., et al. A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage 20 1 (2003) 385-392
73. Hazlett E.A., New A.S., Newmark R., et al. Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry 58 8 (2005) 614-623
74. De La Fuente J.M., Goldman S., Stanus E., et al. Brain glucose metabolism in borderline personality disorder. J Psychiatr Res 31 5 (1997) 531-541
75. Soloff P.H., Meltzer C.C., Greer P.J., et al. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry 47 (2000) 540-547
76. Oquendo M.A., Krunic A., Parsey R.V., et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder. Neuropsychopharmacology 30 6 (2005) 1163-1172
77. Juengling F.D., Schmahl C., Hesslinger B., et al. Positron emission tomography in female patients with borderline personality disorder. J Psychiatr Res 37 2 (2003) 109-115
78. Siever L.J., Buchsbaum M., New A., et al. d,l- fenfluramine response in impulsive personality disorder assessed with 18F-deoxyglucose positron emission tomography. Neuropsychopharmacology 20 5 (1999) 413-423
79. New A., Hazlett E., Buchsbaum M.S., et al. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chloropiperazine in impulsive aggression. Arch Gen Psychiatry 59 7 (2002) 621-629
80. Phillips M.L., Bullmore E.T., Howard R., et al. Investigation of facial recognition memory and happy and sad facial expression perception: an fMRI study. Psychiatry Res 83 3 (1998) 127-138
81. Sprengelmeyer R., Rausch M., Eysel U.T., et al. Neural structures associated with recognition of facial expressions of basic emotions. Proc Biol Sci 265 1409 (1998) 1927-1931
82. New A.S., Buchsbaum M.S., Hazlett E.A., et al. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl) 176 3-4 (2004) 451-458
83. Leyton M., Okazawa H., Diksic M., et al. Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 158 5 (2001) 775-782
84. Frankle W.G., Lombardo I., New A., et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Pyschiatry 162 5 (2005) 915-923
85. Koch W., Schaaff N., Popperl G., et al. [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. J Psychiatry Neurosci 32 4 (2007) 234-240
86. Orr S.P., Metzger L.J., Lasko N.B., et al. De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. J Abnorm Psychol 109 2 (2000) 290-298
87. Peri T., Ben-Shakhar G., Orr S.P., et al. Psychophysiologic assessment of aversive conditioning in posttraumatic stress disorder. Biol Psychiatry 47 6 (2000) 512-519
88. Anderson M.C., Ochsner K.N., Kuhl B., et al. Neural systems underlying the suppression of unwanted memories. Science 303 5655 (2004) 232-235
89. Sanislow C.A., Grilo C.M., and McGlashan T.H. Factor analysis of the DSM-III-R borderline personality disorder criteria in psychiatric inpatients. Am J Psychiatry 157 10 (2000) 1629-1633
90. Johansen M., Karterud S., Pedersen G., et al. An investigation of the prototype validity of the borderline DSM-IV construct. Acta Psychiatr Scand 109 4 (2004) 289-298
91. Fossati A., Madeddu F., and Maffei C. Borderline personality disorder and childhood sexual abuse: a meta-analytic study. J Personal Disord 13 3 (1999) 268-280
92. Schmahl C.G., Elzinga B.M., Vermetten E., et al. Neural correlates of memories of abandonment in women with and without borderline personality disorder. Biol Psychiatry 54 2 (2003) 142-151
93. Minzenberg M.J., Fan J., New A.S., et al. Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Res 155 3 (2007) 231-243
94. Schnell K., Dietrich T., Schnitker R., et al. Processing of autobiographical memory retrieval cues in borderline personality disorder. J Affect Disord 97 1-3 (2007) 253-259
95. Schnell K., and Herpertz S.C. Effects of dialectic-behavioral-therapy on the neural correlates of affective hyperarousal in borderline personality disorder. J Psychiatr Res 41 10 (2007) 837-847
96. Schmahl C., Bohus M., Esposito F., et al. Neural correlates of antinociception in borderline personality disorder. Arch Gen Psychiatry 63 6 (2006) 659-667
97. Coccaro E.F., McCloskey M.S., Fitzgerald D.A., et al. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biol Psychiatry 62 2 (2007) 168-178
98. LeDoux J. Emotion circuits in the brain. Annu Rev Neurosci 23 (2000) 155-184
99. Fitzgerald D.A., Angstadt M., Jelsone L.M., et al. Beyond threat: amygdala reactivity across multiple expressions of facial affect. Neuroimage 30 4 (2006) 1441-1448
100. Phelps E.A., and LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48 2 (2005) 175-187
101. Driessen M., Herrmann J., Stahl K., et al. Magnetic resonance imaging volumes of the hippocampus and the amgydala in women with borderline personality disorder and early traumatization. Arch Gen Psychiatry 57 12 (2000) 1115-1122
102. Schmahl C.G., Vermetten E., Elzinga B.M., et al. Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Res 122 3 (2003) 193-198
103. Brambilla P., Soloff P.H., Sala M., et al. Anatomical MRI study of borderline personality disorder patients. Psychiatry Res 131 2 (2004) 125-133
104. Zetzsche T., Frodl T., Preuss U.W., et al. Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biol Psychiatry 60 3 (2006) 302-310
105. New A.S., Hazlett E.A., Buchsbaum M.S., et al. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 32 7 (2007) 1629-1640
106. Herpertz S., Dietrich T., Wenning B., et al. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry 50 4 (2001) 292-298
107. Donegan N.H., Sanislow C.A., Blumberg H.P., et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry 54 11 (2003) 1284-1293
108. Pietrini P., Guazzelli M., Basso G., et al. Neural correlates of imaginal aggressive behavior assessed by positron emission tomography in healthy subjects. Am J Psychiatry 157 11 (2000) 1772-1781
109. Irle E., Lange C., and Sachsse U. Reduced size and abnormal asymmetry of parietal cortex in women with borderline personality disorder. Biol Psychiatry 57 2 (2005) 173-182
110. Zetzsche T., Preuss U.W., Frodl T., et al. Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Psychiatry Res 154 2 (2007) 157-170
111. Beblo T., Driessen M., Mertens M., et al. Functional MRI correlates of the recall of unresolved life events in borderline personality disorder. Psychol Med 36 6 (2006) 845-856
112. Schnell K., Dietrich T., Schnitker R., et al. Processing of autobiographical memory retrieval cues in borderline personality disorder. J Affect Disord 97 1-3 (2007) 253-259
113. Nimchinsky E.A., Gilissen E., Allman J.M., et al. A neuronal morphologic type unique to humans and great apes. Proc Natl Acad Sci U S A 96 9 (1999) 5268-5273
114. Parr L.A., Waller B.M., and Fugate J. Emotional communication in primates: implications for neurobiology. Curr Opin Neurobiol 15 6 (2005) 716-720
115. Rizzolatti G., and Craighero L. The mirror-neuron system. Annu Rev Neurosci 27 (2004) 169-192
116. Singer T., Seymour B., O'Doherty J., et al. Empathy for pain involves the affective but not sensory components of pain. Science 303 5661 (2004) 1157-1162
117. Botvinick M., Jha A.P., Bylsma L.M., et al. Viewing facial expressions of pain engages cortical areas involved in the direct experience of pain. Neuroimage 25 1 (2005) 312-319
118. Allman J.M., Watson K.K., Tetreault N.A., et al. Intuition and autism: a possible role for Von Economo neurons. Trends Cogn Sci 9 8 (2005) 367-373
119. de Vignemont F., and Singer T. The empathic brain: how, when and why?. Trends Cogn Sci 10 10 (2006) 435-441
120. Saarela M.V., Hlushchuk Y., Williams A.C., et al. The compassionate brain: humans detect intensity of pain from another's face. Cereb Cortex 17 1 (2007) 230-237
121. Jackson P.L., Brunet E., Meltzoff A.N., et al. Empathy examined through the neural mechanisms involved in imagining how I feel versus how you feel pain. Neuropsychologia 44 5 (2006) 752-761
122. Bartels A., and Zeki S. The neural correlates of maternal and romantic love. Neuroimage 21 3 (2004) 1155-1166
123. Leibenluft E., Gobbini M.I., Harrison T., et al. Mothers' neural activation in response to pictures of their children and other children. Biol Psychiatry 56 4 (2004) 225-232
124. Paris J. The diagnosis of borderline personality disorder: problematic but better than the alternatives. Ann Clin Psychiatry 17 1 (2005) 41-46
125. Bailey J.M., and Shriver A. Does childhood sexual abuse cause borderline personality disorder?. J Sex Marital Ther 25 1 (1999) 45-57
126. Paris J., and Zweig-Frank H. A 27-year follow-up of patients with borderline personality disorder. Compr Psychiatry 42 6 (2001) 482-487
127. Zanarini M. Pharmacological treatment of borderline personality disorder: two 12-week randomized double-blind placebo-controlled trials. Paper presented at: NCDEU 46th Annual Meeting. Boca Rotan, Florida, June 14, 2006.
128. Zhang T.Y., Bagot R., Parent C., et al. Maternal programming of defensive responses through sustained effects on gene expression. Biol Psychol 73 1 (2006) 72-89
129. Insel T.R., and Young L.J. The neurobiology of attachment. Nat Rev Neurosci 2 2 (2001) 129-136
130. Dickey C.C., McCarley R.W., Niznikiewicz M.A., et al. Clinical, cognitive, and social characteristics of a sample of neuroleptic-naive persons with schizotypal personality disorder. Schizophr Res 78 2-3 (2005) 297-308
131. Matsui M., Sumiyoshi T., Kato K., et al. Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia. Psychol Rep 94 2 (2004) 387-397
132. Kety S.S., Rosenthal D., Wender P.H., et al. Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic. Behav Genet 6 3 (1976) 219-225
133. Tienari P., Wynne L.C., Laksy K., et al. Genetic boundaries of the schizophrenia spectrum: evidence from the Finnish Adoptive Family Study of Schizophrenia. Am J Psychiatry 160 9 (2003) 1587-1594
134. Kendler K.S., Gruenberg A.M., and Strauss J.S. An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia II. The relationship between schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry 38 (1981) 982-987
135. Kendler K.S. Schizophrenia genetics and dysbindin: a corner turned?. Am J Psychiatry 161 9 (2004) 1533-1536
136. Squires-Wheeler E., Skodol A.E., Bassett A., et al. DSM-III-R schizotypal personality traits in offspring of schizophrenic disorder, affective disorder, and normal control parents. J Psychiatr Res 23 3-4 (1989) 229-239
137. Koenigsberg H.W., Reynolds D., Goodman M., et al. Risperidone in the treatment of schizotypal personality disorder. J Clin Psychiatry 64 6 (2003) 628-634
138. Mitropoulou V., Harvey P.D., Maldari L.A., et al. Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol Psychiatry 52 12 (2002) 1175-1182
139. Mitropoulou V., Harvey P.D., Zegarelli G., et al. Neuropsychological performance in schizotypal personality disorder: importance of working memory. Am J Psychiatry 162 10 (2005) 1896-1903
140. Voglmaier M.M., Seidman L.J., Niznikiewicz M.A., et al. Verbal and nonverbal neuropsychological test performance in subjects with schizotypal personality disorder. Am J Psychiatry 157 (2000) 787-793
141. Avila M.T., Adami H.M., McMahon R.P., et al. Using neurophysiological markers of genetic risk to define the boundaries of the schizophrenia spectrum phenotype. Schizophr Bull 29 2 (2003) 299-309
142. Siever L.J., Keefe R., Bernstein D.P., et al. Eye tracking impairment in clinically identified schizotypal personality disorder patients. Am J Psychiatry 147 (1990) 740-745
143. Thaker G.K., Cassady S., Adami H., et al. Eye movements in spectrum personality disorders: comparison of community subjects and relatives of schizophrenic patients. Am J Psychiatry 153 3 (1996) 362-368
144. Cadenhead K.S., Light G.A., Geyer M.A., et al. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry 157 (2000) 55-59
145. Cadenhead K.S., Geyer M.A., and Braff D.L. Impaired startle prepulse inhibition and habituation in schizotypal patients. Am J Psychiatry 150 (1993) 1862-1867
146. Siever L.J. Endophenotypes in the personality disorders. Dialogues Clin Neurosci 7 2 (2005) 139-151
147. Buchsbaum M., Yang S., Hazlett E., et al. Ventricular volume and assymetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging. Schizophr Res 27 (1997) 45-53
148. Downhill J.E., Buchsbaum M.S., Wei T.S., et al. Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder. Schizophr Res 42 (2000) 193-208
149. Buchsbaum M.S., Nenadic I., Hazlett E., et al. Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res 54 1-2 (2002) 141-150
150. Hazlett E.A., Buchsbaum M.S., Byne W., et al. Three-dimensional analysis with MRI and PET of the size, shape and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry 156 (1999) 1190-1199
151. Shihabuddin L., Buchsbaum M.S., Hazlett E.A., et al. Striatal size and glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry 58 (2001) 877-884
152. Mitropoulou V., Goodman M., Sevy S., et al. Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder. Schizophr Res 70 1 (2004) 27-31
153. Kirrane R.M., and Siever L.J. New perspectives on schizotypal personality disorder. Curr Psychiatry Rep 2 (2000) 62-66
154. Siever L.J., and Davis K.L. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am J Psychiatry 161 3 (2004) 398-413
155. Minzenberg M.J., Fan J., New A.S., et al. Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res (2007 Sep 6) [Epub ahead of print]
156. Tebartz van Elst L., Ludaescher P., Thiel T., et al. Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder. Neurosci Lett 417 1 (2007) 36-41
157. Soloff P.H., Price J.C., Meltzer C.C., et al. 5HT(2A) receptor binding is increased in borderline personality disorder. Biological Psychiatry 62 6 (2007) 580-587
158. Lange C., Kracht L., Herholz K., et al. Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder. Psychiatry Res 139 2 (2005) 115-126
159. Soloff P.H., Meltzer C.C., Becker C., et al. Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder. Psychiatry Res 138 3 (2005) 183-195
160. Zanettini R., Antonini A., Gatto G., et al. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 356 1 (2007) 39-46
161. Rusch N., Weber M., Il'yasov K.A., et al. Inferior frontal white matter microstructure and patterns of psychopathology in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. Neuroimage 35 2 (2007) 738-747